- Index
- >Publications
Recently published
|
|
|
Internalization and mechanisms of toxicity of lipid nanocapsules in HepG2 and HepaRG hepatoma cells upon acute and chronic exposures Emilie Roger, Jérome Bejaud, Pascal Loyer, Frédéric Lagarce, Camille C. Savary |
|
|
|
Nanomedicines via the pulmonary route: a promising strategy to reach the target? Mélina Guerin & Elise Lepeltier link to publisher link to intranet
|
|
|
|
Investigating the Reactivity of a Novel Methacrylic Transmer in Solution RAFT-SCVP and Its Impact on the Structure of the Resulting Hyperbranched Polymers Typhaine Despres, Tiffaine Fabre, Samuel Legeay, Guillaume Bastiat, Franck D’Agosto, Muriel Lansalot, Morwenna S. M. Pearson-Long, Sandie Piogé, and Sagrario Pascual |
|
|
|
MicroRNA-targeting nanomedicines for the treatment of intervertebral disc degeneration Hussein H Genedy , Paul Humbert , Bilel Laoulaou, Brian Le Moal , Marion Fusellier , Catherine Passirani , Catherine Le Visage , Jérôme Guicheux , Élise Lepeltier & Johann Clouet |
|
|
|
Caliper, contrast enhanced-ultrasound or laser speckle contrast imaging: Techniques to follow mice melanoma growth Adélie Mellinger, Jeanne Hersant, Clara Bourreau, Simon Lecoq, Eva Deveze, Nicolas Clere & Samir Henni |
|
|
|
Electrochemical Nucleic Acid Biosensor on a Microfluidic Chip to Understand the Coupling between Electrochemistry and Microfluidics Marie-Charlotte Horny, MartinaFreisa, ClairePoujouly, Pedro Gonzalez-Losada, Jeremy Le Gall, Thi-Hong-Nhung Dinh, David Bouville, Isabelle Le Potier,Antoine Pallandre and Jean Gamby |
|
|
|
Diversely substituted poly(N-vinyl amide) derivates towards non-toxic, stealth and pH-responsive lipid nanocapsules F. Toussaint, E. Lepeltier, F. Franconi, V Pautu, C Jérôme, C. Passirani & A Debuigne |
|
|
|
Investigating the functionalization of liposomes with NFL-TBS. 40-63 peptides as a promising drug delivery system M-A Jourdain, A. Dupont, N. Lautram & J. eyer |
|
|
|
The use of liposomes functionalized with the NFL-TBS.40–63 peptide as a targeting agent to cross the in vitro blood–brain barrier and target glioblastoma cells Adélie Mellinger, Larissa J. Lubitz, Claire Gazaille, Gero Leneweit, Guillaume Bastiat, Claire Lépinoux-Chambaud & Joel Eyer |
|
|
|
Evidence of residual micellar structures in a lipid nanocapsule dispersion. A multi-technique approach Emilie Roger, Florence Franconi, Tran Anh Thu Do, Carl Simonsson, Benjamin Siegler, Rodolphe Perrot, Patrick Saulnier, Jean-Christophe Gimel |
|
|
|
Contact angle of ethanol, water, and their mixtures on stainless steel surfaces in dense carbon dioxide |
|
|
|
3D multi-cell-type liver organoids: A new model of non-alcoholic fatty liver disease for drug safety assessments |
|
|
|
Protein corona formation on lipidic nanocapsules: Influence of the interfacial PEG repartition Vincent Lebreton, Samuel Legeay, Anastasiia Vasylaki, Fredéric Lagarce, Patrick Saulnier link to publisher link to intranet
|
|
|
|
Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel Claire Gazaille , Elia Bozzato, Neda Madadian-Bozorg, Adélie Mellinger, Marion Sicot, Umer Farooq, Patrick Saulnier, Joël Eyer, Véronique Préat, Nicolas Bertrand, Guillaume Bastiat |
|
|
|
Formulation of benznidazole-lipid nanocapsules: Drug release, permeability, biocompatibility, and stability studies Eva C Arrua, Olga Hartwig, Brigitta Loretz, Xabier Murgia, Duy-Khiet Ho, Guillaume Bastiat, Claus-Mickael Lehr & Claudio J Salomon |
|
|
|
Dedifferentiated cells obtained from glioblastoma cell lines are an easy and robust model for mesenchymal glioblastoma stem cells studies Cécile Doualle, Julien Gouju, Yousra Nouari, Méline Wery, Clélia Guittonneau, Philippe Codron, Audrey Rousseau, Patrick Saulnier, Joël Eyer, Franck Letournel
|
|
|
|
Physicochemical Characterization of Ferrocifen Lipid Nanocapsules: Customized Drug Delivery Systems Guided by the Molecular Structure Pierre Idlas, Elise Lepeltier, Guillaume Bastiat, Pascal Pigeon, Michael J. McGlinchey, Nolwenn Lautram, Anne Vessières, Gerard Jaouen, and Catherine Passirani |
|
|
|
Therapeutic strategies for non-small cell lung cancer: Experimental models and emerging biomarkers to monitor drug efficacies Clara Bourreau, Lucas Treps, Sébastien Faure, Delphine Fradin & nicolas Clère |
|
|
|
Investigation on the self-assembly of the NFL-TBS.40-63 peptide and its interaction with gold nanoparticles as a delivery agent for glioblastoma H. Alnemeh-Al Ali, A. Griveau, F. Artzner, A. Dupont, N. Lautram, M.A. Jourdain & J. Eyer |
|
|
|
Fludioxonil, a phenylpyrrol pesticide, induces Cytoskeleton disruption, DNA damage and apoptosis via oxidative stress on rat glioma cells |
|
|
|
Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique Lebreton V, Kaeokhamloed N, Vasylaki A, Hilairet G, Mellinger A, Béjaud J, Saulnier P, Lagarce F, Gattacceca F, Legeay S & Roger E |
|
|
|
Characterization and quantification of the interaction between the NFL-TBS.40‐63 peptide and lipid nanocapsules A. Griveau, H. Alnemeh-Al Ali, M.A. Jourdain, A. Dupont, J. Eyer |
|
|
|
Biological activity of gold nanoparticles combined with the NFL-TBS.40-63 peptide, or with other cell penetrating peptides, on rat glioblastoma cells. Griveau A, Arib C, Spadavecchia J, Eyer J. |
|
|
|
Ferrocifen stealth LNCs and conventional chemotherapy: A promising combination against multidrug-resistant ovarian adenocarcinoma Idlas P, Ladaycia A, Némati F, Lepeltier E, Pigeon P, Jaouen G, Decaudin D & Passirani C |
|
|
|
Cell penetrating peptide (CPP) gold(iii) – complex – bioconjugates: from chemical design to interaction with cancer cells for nanomedicine applications Arib C, Griveau A, Eyer J & Spadavecchia J |
|
|
|
Reactive precipitation of vaterite calcium carbonate microspheres insupercritical carbon dioxide-water dispersion by microfluidics Legout P, Lefebvre G, Bonnin M, Gimel JC, Benyahia L, Gibaud A, Marre S, Simonsson C, Wang S, Colombani O & Calvignac B |
Mint's publications
